A polymeric epitope-based vaccine has been found to induce protective immunity against group A Streptococcus. Research in this area is ongoing, with various approaches being explored, including nanoparticle-based antigen delivery and peptide vaccines, to target infectious pathogens. The development of vaccines against group A Streptococcus and other bacterial infections is an active area of investigation, with multiple strategies and technologies being considered.